Verastem Oncology (NASDAQ: VSTM) has recently announced positive updated safety and efficacy results from the ramp 205 phase 1/2 trial, which is evaluating avutometinib plus defactinib in combination ...

An international study has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients with the therapies ...

This revision follows the commencement of a new Olympic Cycle post-Paris Olympics 2024, meeting in mind India’s aspirations ...

Eli Lilly and Company today announced that data from studies of imlunestrant, an investigational oral selective estrogen receptor degrader (SERD), olomorasib, an investigational KRAS G12C inhibitor, ...

To file Nil Returns, all you need is a KRA PIN, access to the iTax portal, and a reliable internet connection.

Thirteen sports in India will soon have league culture, basketball, badminton, archery, boxing, wrestling, white water sports ...

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute ...

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute ...

Silexion’s new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to address critical unmet needs in additional ...

The company reported revenue from operations at ₹1,000 crore, up 2.7%YoY over ₹973.6 crore reported in Q4 FY24.